Abstract
The Editors-in-Chief would like to alert readers that this article (Sitapara et al. 2014) is part of an investigation being conducted by the journal following the conclusions of an institutional enquiry at the University of Liverpool with respect to the quantitative mass spectrometry-generated results regarding acetylated and redox-modified HMGB1.
Expression of Concern to: Mol Med
https://doi.org/10.2119/molmed.2013.00086
The Editors-in-Chief would like to alert readers that this article (Sitapara et al. 2014) is part of an investigation being conducted by the journal following the conclusions of an institutional enquiry at the University of Liverpool with respect to the quantitative mass spectrometry-generated results regarding acetylated and redox-modified HMGB1. Appropriate editorial action will be taken once the investigation is concluded.
Lokesh Sharma, Charles R. Ashby Jr., Saamir Gorasiya, Huan Yang, and Lin L. Mantell agree to this editorial expression of concern.
Ravikumar A. Sitapara, Vivek S. Patel, and Daniel J. Antoine have not responded to any correspondence from the editor/publisher about this editorial expression of concern.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- Sitapara, et al. The α7 nicotine acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Mol Med. 2014;20:238–247. doi: 10.2119/molmed.2013.00086. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]